What is the share price of Vimta Labs Ltd (VIMTALABS) today?
The share price of VIMTALABS as on 4th December 2025 is ₹607.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Vimta Labs Ltd (VIMTALABS) share?
The past returns of Vimta Labs Ltd (VIMTALABS) share are- Past 1 week: -2.09%
- Past 1 month: -9.24%
- Past 3 months: -23.68%
- Past 6 months: 26.57%
- Past 1 year: 29.79%
- Past 3 years: 170.10%
- Past 5 years: 663.63%
What are the peers or stocks similar to Vimta Labs Ltd (VIMTALABS)?
The peers or stocks similar to Vimta Labs Ltd (VIMTALABS) include:What is the dividend yield % of Vimta Labs Ltd (VIMTALABS) share?
The current dividend yield of Vimta Labs Ltd (VIMTALABS) is 0.16.What is the market cap of Vimta Labs Ltd (VIMTALABS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vimta Labs Ltd (VIMTALABS) is ₹2713.15 Cr as of 4th December 2025.What is the 52 week high and low of Vimta Labs Ltd (VIMTALABS) share?
The 52-week high of Vimta Labs Ltd (VIMTALABS) is ₹902.65 and the 52-week low is ₹391.85.What is the PE and PB ratio of Vimta Labs Ltd (VIMTALABS) stock?
The P/E (price-to-earnings) ratio of Vimta Labs Ltd (VIMTALABS) is 40.30. The P/B (price-to-book) ratio is 7.16.Which sector does Vimta Labs Ltd (VIMTALABS) belong to?
Vimta Labs Ltd (VIMTALABS) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Vimta Labs Ltd (VIMTALABS) shares?
You can directly buy Vimta Labs Ltd (VIMTALABS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Vimta Labs Ltd
VIMTALABS Share Price
607.850.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
VIMTALABS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
VIMTALABS Performance & Key Metrics
VIMTALABS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.50 | 7.16 | 0.16% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.94 | 5.83 | 0.58% |
VIMTALABS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
VIMTALABS Company Profile
Vimta Labs Limited is engaged in providing testing and contract research services in the fields of clinical and pre-clinical studies, clinical reference, analytical testing, advanced molecular biology and environmental studies.
DIVISLAB
PE Ratio
78.38
78.38
1Y Return
3.40%
3.40%
Buy Reco %
54.17
54.17
SYNGENE
PE Ratio
52.00
52.00
1Y Return
30.79%
30.79%
Buy Reco %
83.33
83.33
AARTIPHARM
PE Ratio
24.08
24.08
1Y Return
10.47%
10.47%
Buy Reco %
0.00
0.00
PE Ratio
1,106.00
1,106.00
1Y Return
12.02%
12.02%
Buy Reco %
0.00
0.00
PE Ratio
73.13
73.13
1Y Return
20.87%
20.87%
Buy Reco %
0.00
0.00
VIMTALABS Sentiment Analysis
VIMTALABS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
VIMTALABS Stock Summary · July 2025
In Q1 FY '26, the company showcased robust financial performance, achieving record revenues driven by its pharmaceutical testing services, which constitute a significant portion of its business. Management's commitment to quality was underscored by successful FDA inspections and a focus on compliance, particularly as it expands into biologics and electronics testing. While the domestic market faces challenges, particularly in revenue stagnation, export growth remains strong, bolstered by a diverse client base and strategic initiatives aimed at enhancing operational efficiency. The company is poised for future growth, with plans for infrastructure expansion and a cautious yet optimistic outlook on market dynamics, despite potential risks from increased competition and regulatory pressures.
VIMTALABS Stock Growth Drivers
VIMTALABS Stock Growth Drivers
7Strong Financial Performance
Vimta Labs achieved its highest-ever quarterly revenue of INR 993 million in Q1 FY '26,
Regulatory Compliance and Quality Assurance
Vimta Labs successfully completed an unannounced US FDA GCP inspection with no Form 483 observations
VIMTALABS Stock Challenges
VIMTALABS Stock Challenges
5Concerns Over Biotech Funding
There is a significant concern regarding a slowdown in biotech funding in the U.S., which
Uncertain Future of Clinical Trials
The company has completed a Phase II clinical trial, but it is still too early
VIMTALABS Forecast
VIMTALABS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
VIMTALABS
VIMTALABS
Income
Balance Sheet
Cash Flow
Annual Normal View
VIMTALABS Income Statement
VIMTALABS Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 154.79 | 184.65 | 214.57 | 183.69 | 209.86 | 277.43 | 318.59 | 292.31 | 348.81 | 395.03 | ||||||||||
Raw Materials | 30.39 | 29.53 | 35.64 | 32.41 | 35.25 | 40.96 | 42.15 | 34.55 | 43.47 | 249.74 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 10.78 | 10.24 | 11.31 | 14.39 | 12.32 | 12.67 | |||||||||||
| Employee Cost | 43.15 | 49.10 | 55.19 | 57.59 | 57.28 | 70.85 | 85.62 | 85.19 | 91.28 | |||||||||||
| Selling & Administrative Expenses | 21.07 | 23.22 | 24.29 | 26.44 | 21.24 | 28.03 | 42.65 | 32.08 | 39.05 | |||||||||||
| Operating & Other expenses | 31.92 | 36.34 | 39.98 | 23.44 | 32.35 | 46.28 | 36.76 | 38.22 | 35.57 | |||||||||||
EBITDA | 28.26 | 46.46 | 59.47 | 33.03 | 53.50 | 80.00 | 97.02 | 89.95 | 126.77 | 145.29 | ||||||||||
| Depreciation/Amortization | 9.63 | 15.70 | 19.72 | 20.92 | 22.94 | 23.16 | 30.54 | 33.14 | 35.29 | 39.12 | ||||||||||
| PBIT | 18.63 | 30.76 | 39.75 | 12.11 | 30.56 | 56.84 | 66.48 | 56.81 | 91.48 | 106.17 | ||||||||||
| Interest & Other Items | 2.09 | 5.20 | 4.61 | 3.77 | 2.17 | 1.50 | 2.64 | 2.10 | 1.90 | 1.71 | ||||||||||
| PBT | 16.54 | 25.56 | 35.14 | 8.34 | 28.39 | 55.34 | 63.84 | 54.71 | 89.58 | 104.46 | ||||||||||
| Taxes & Other Items | 5.94 | 9.13 | 9.83 | 1.42 | 7.14 | 14.29 | 16.53 | 13.69 | 22.25 | 25.82 | ||||||||||
| Net Income | 10.60 | 16.43 | 25.31 | 6.92 | 21.25 | 41.05 | 47.31 | 41.02 | 67.33 | 78.64 | ||||||||||
| EPS | 2.40 | 3.72 | 5.72 | 1.57 | 4.81 | 9.28 | 10.69 | 9.26 | 15.16 | 17.68 | ||||||||||
| DPS | 0.00 | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||||
| Payout ratio | 0.00 | 0.27 | 0.17 | 0.00 | 0.21 | 0.11 | 0.09 | 0.11 | 0.07 | 0.06 |
VIMTALABS Company Updates
FY 2026FY 2026
Investor Presentation
Nov 3PDF
Jul 18PDF
Jul 17PDF
Jul 17PDF
VIMTALABS Stock Peers
VIMTALABS Past Performance & Peer Comparison
VIMTALABS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Vimta Labs Ltd | 40.30 | 7.16 | 0.16% |
| Divi's Laboratories Ltd | 78.38 | 11.47 | 0.46% |
| Syngene International Ltd | 52.00 | 5.46 | 0.19% |
| Aarti Pharmalabs Ltd | 24.08 | 3.30 | 0.69% |
VIMTALABS Stock Price Comparison
Compare VIMTALABS with any stock or ETFCompare VIMTALABS with any stock or ETF
VIMTALABS
VIMTALABS Holdings
VIMTALABS Shareholdings
VIMTALABS Promoter Holdings Trend
VIMTALABS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
VIMTALABS Institutional Holdings Trend
VIMTALABS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
VIMTALABS Shareholding Pattern
VIMTALABS Shareholding Pattern
VIMTALABS Shareholding History
VIMTALABS Shareholding History
Foreign Institutions
Mutual Funds Invested in VIMTALABS
Mutual Funds Invested in VIMTALABS
No mutual funds holding trends are available
Top 1 Mutual Funds holding Vimta Labs Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.08% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 86/124 (+1) |
Compare 3-month MF holding change on Screener
smallcases containing VIMTALABS stock
smallcases containing VIMTALABS stock
Looks like this stock is not in any smallcase yet.
VIMTALABS Events
VIMTALABS Events
VIMTALABS Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VIMTALABS has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.16%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.64 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
VIMTALABS Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
VIMTALABS has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.16%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.64 every year
VIMTALABS Upcoming Dividends
VIMTALABS Upcoming Dividends
No upcoming dividends are available
VIMTALABS Past Dividends
VIMTALABS Past Dividends
Cash Dividend
Ex DateEx DateMay 30, 2025
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
May 30, 2025
Cash Dividend
Ex DateEx DateJul 11, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jul 11, 2024
Cash Dividend
Ex DateEx DateJun 21, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jun 21, 2023
Cash Dividend
Ex DateEx DateJun 16, 2022
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jun 16, 2022
Cash Dividend
Ex DateEx DateJun 25, 2021
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Jun 25, 2021
VIMTALABS Stock News & Opinions
VIMTALABS Stock News & Opinions
Articles & Videos
Corporate
Vimta Labs allots 94,369 equity shares under ESOP
Vimta Labs has allotted 94,369 equity shares under ESOP on 17 November 2025. With this allotment, the paid up equity share capital has increased to Rs 8,92,70,378 consisting of 4,46,35,189 equity shares having a face value of Rs 2 each. Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Vimta Labs standalone net profit rises 30.62% in the September 2025 quarter
Net profit of Vimta Labs rose 30.62% to Rs 19.92 crore in the quarter ended September 2025 as against Rs 15.25 crore during the previous quarter ended September 2024. Sales rose 20.19% to Rs 101.85 crore in the quarter ended September 2025 as against Rs 84.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales101.8584.74 20 OPM %33.6035.31 - PBDT36.5130.19 21 PBT26.2721.90 20 NP19.9215.25 31 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Vimta Labs to declare Quarterly Results
Vimta Labs will hold a meeting of the Board of Directors of the Company on 3 November 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Vimta Labs standalone net profit rises 53.83% in the June 2025 quarter
Net profit of Vimta Labs rose 53.83% to Rs 18.89 crore in the quarter ended June 2025 as against Rs 12.28 crore during the previous quarter ended June 2024. Sales rose 30.29% to Rs 97.56 crore in the quarter ended June 2025 as against Rs 74.88 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales97.5674.88 30 OPM %34.5234.62 - PBDT35.1126.14 34 PBT25.2518.16 39 NP18.8912.28 54 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Vimta Labs announces board meeting date
Vimta Labs will hold a meeting of the Board of Directors of the Company on 17 July 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Vimta Labs allots Equity Shares
Vimta Labs has approved the allotted 2,22,52,784 equity shares of Rs. 2/- each as fully-paid up bonus equity shares on 14th June 2025, in the ratio of One (1) equity share for every One (1) equity share, to the eligible Members whose names appear in the register of Members/list of beneficial owners as on 13th June 2025, being the record date fixed for this purpose.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Vimta Labs cancels board meeting
Vimta Labs has cancelled the board meeting which was scheduled to be held on 14 June 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Vimta Labs to conduct board meeting
Vimta Labs will hold a meeting of the Board of Directors of the Company on 14 June 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Vimta Labs allots 18,272 equity shares under ESOP
Vimta Labs has allotted 18,272 equity shares under ESOP on 23 May 2025. The paid-up share capital of the Company has accordingly increased from Rs. 4,44,69,024 consisting of 2,22,34,512 equity shares having a face value of Rs. 2 each to Rs. 4,45,05,568 consisting of 2,22,52,784 equity shares having a face value of Rs. 2 each.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Vimta Labs to hold AGM
Vimta Labs announced that the 35th Annual General Meeting(AGM) of the company will be held on 6 June 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 13.68%, vs industry avg of 7.49%
Over the last 5 years, market share increased from 1.51% to 1.76%
Over the last 5 years, net income has grown at a yearly rate of 57.62%, vs industry avg of 8.2%